Governance Classic Home
Unichem Laboratories LtdPharmaceuticalsINE351A01035Consolidated₹545.70+7.25 (+1.35%)Jun-26
Valuation
Market Cap₹3.84K Cr
TTM PE12.40x
Forward PE8.96x
PEG0.55
Book Value₹385.97
P/B1.41x
TTM EPS₹44.01
Fwd EPS₹60.93
TTM Revenue₹2.31K Cr
TTM PAT₹304.78 Cr
TTM EBITDA₹228.58 Cr
TTM EBIT₹105.31 Cr
Last Qtr PAT₹41.47 Cr
Last Qtr EBITDA₹69.94 Cr
Last Qtr EBIT₹40.00 Cr
Profitability
ROE11.22%
ROCE12.21%
TTM NPM13.21%
TTM EBITDA %9.90%
Curr OPM6.40%
Last OPM1.82%
Curr NPM—
Last NPM—
Curr EPS₹6.61
Last EPS₹1.55
Balance sheet
Equity₹14.08 Cr
Reserve₹2.70K Cr
Total Debt₹500.15 Cr
D/E0.18x
Interest %15.96%
Curr Interest₹6.62 Cr
Price / range
Close₹545.70
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D+1.35%
1W+1.11%
1M+3.04%
3M+21.73%
6M+70.08%
1Y+7.35%
2Y-16.56%
3Y+33.46%
5Y+99.27%
Diwali+24.07%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1837.30₹4.41L Cr36.4514.50%
DIVISLAB9375.00₹2.49L Cr85.0617.45%
TORNTPHARM4840.00₹1.84L Cr77.3225.70%
ZYDUSLIFE1160.00₹1.16L Cr25.8516.94%
CIPLA1394.50₹1.13L Cr33.419.75%
LAURUSLABS1954.00₹1.06L Cr96.4520.58%
AUROPHARMA1734.00₹99.77K Cr27.099.79%
DRREDDY1185.00₹98.91K Cr30.638.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue366.27-4.7%356.24314.90356.90384.251,412.29
Other Income16.7222.2215.0321.404.2562.90
Total Income382.99-1.4%378.46329.93378.30388.501,475.19
Interest1.294.092.103.681.9311.80
Expenditure-375.61+3.8%-376.81-345.63-382.99-390.37-1,492.76
PBDT000000
EBITDA20.64-19.8%12.491.397.7025.7450.36
Depreciation-28.69-28.97-30.02-30.11-29.93-119.03
EBIT-8.05-92.1%-16.48-28.63-22.41-4.19-68.67
PBT7.38+494.7%-10.71259.82-37.83-1.87209.41
Tax-1.85-4.68-43.71-2.100.02-50.47
Equity14.0814.080014.0814.08
OPM1.93-2.8382.51-10.60-0.4814.20
Net Profit5.53+398.9%-15.39216.11-39.93-1.85158.94
NPM1.44-4.0768.63-11.19-0.4810.77
EPS0.79+403.8%-2.1930.69-5.67-0.2622.57

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue1,412.29-18.6%1,735.70+20.4%1,442.17+34.5%1,072.43+13.7%942.93-16.1%1,123.97
Other Income62.9040.8330.3941.8542.0747.37
Total Income1,475.19-17.0%1,776.53+20.6%1,472.55+32.2%1,114.28+13.1%985-15.9%1,171.34
Expenditure-1,492.76+6.6%-1,597.85-6.0%-1,507.13-17.7%-1,280.71-19.5%-1,071.74+3.1%-1,105.70
Interest-11.80-7.62-10.42-9.38-2.07-1.30
PBDT000000
EBITDA50.36-80.2%253.88+398.6%50.92+154.8%-92.92-113.4%-43.55-145.6%95.46
Depreciation-119.03-108.41-105.46-105.98-83.19-75.89
EBIT-68.67-147.2%145.47+366.7%-54.54+72.6%-198.90-56.9%-126.74-747.6%19.57
PBT209.41+14.6%182.68+298.2%-92.18+67.0%-279.09-221.7%-86.75-232.1%65.65
Tax-50.47-19.720-20.6131.32-11.56
Equity14.0814.080000
OPM (%)14.2010.28-6.00-25.00-9.006.00
Net Profit158.94-2.5%162.96+276.8%-92.18+69.2%-299.70-440.7%-55.43-202.5%54.08
NPM (%)10.779.17-6.00-27.00-6.005.00
EPS (Rs)22.57-2.5%23.15+276.9%-13.09+69.3%-42.57-440.9%-7.87-202.5%7.68
CEPS22.5323.08-13.09-42.57-7.877.68

Consolidated

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue632.62+20.1%575.12521.17578.96526.602,201.85
Other Income15.6123.4711.8020.976.8263.06
Total Income648.23+21.5%598.59532.97599.93533.422,264.91
Interest6.629.397.428.246.5431.59
Expenditure-599.24-10.5%-567.44-515.06-552.49-542.44-2,174.39
PBDT000000
EBITDA69.94+211.0%47.6844.7866.1822.49184.17
Depreciation-29.94-30.61-31.25-31.47-31.79-125.12
EBIT40+530.1%17.0713.5334.71-9.3059.05
PBT48.99+643.1%18.79293.430-9.02292.38
Tax-7.52-7.88-29.14-1.07-1.45-39.54
Equity14.0814.080014.0814.08
OPM7.563.1455.060.00-1.6912.91
Net Profit41.47+496.1%10.91264.29-11.89-10.47252.84
NPM6.401.8249.59-1.98-1.9611.16
EPS6.61+543.6%1.5537.54-1.69-1.4935.91

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue2,201.85+4.3%2,110.97+23.8%1,704.90+26.9%1,343.02+5.8%1,269.83+2.8%1,235.14
Other Income63.0635.3231.6038.5247.5150.19
Total Income2,264.91+5.5%2,146.29+23.6%1,736.49+25.7%1,381.54+4.9%1,317.34+2.5%1,285.32
Expenditure-2,174.39-9.2%-1,991.70-14.4%-1,740.55-14.6%-1,519.33-17.4%-1,294.31-4.9%-1,233.50
Interest-31.59-21.03-22.66-17.31-6.11-5.12
PBDT000000
EBITDA184.17-30.5%264.86+164.2%100.25+320.0%-45.56-162.6%72.80-20.1%91.12
Depreciation-125.12-124.56-113.24-113.44-91.17-84.36
EBIT59.05-57.9%140.30+1180.1%-12.99+91.8%-159-765.5%-18.37-371.7%6.76
PBT292.38+89.1%154.59+350.7%-61.67+65.0%-176.36-865.8%23.03-55.6%51.82
Tax-39.54-17.07-8.81-25.8711.09-17.16
Equity14.0814.080000
OPM (%)12.917.20-3.55-12.771.754.03
Net Profit252.84+83.9%137.52+295.1%-70.47+65.2%-202.23-711.7%33.06-3.7%34.33
NPM (%)11.166.41-4.06-14.642.512.67
EPS (Rs)35.91+83.9%19.53+295.1%-10.01+65.1%-28.72-711.1%4.70-3.7%4.88
CEPS35.8519.47-10.01-28.724.684.88

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

19
YearTypeAmountEx-Date
2022Final Dividend401 Aug 2022
2021Final Dividend422 Jul 2021
2020Final Dividend420 Aug 2020
2019Final Dividend418 Jul 2019
2018Final Dividend519 Jul 2018
2017Final Dividend313 Jul 2017
2016Interim Dividend217 Mar 2016
2015Final Dividend202 Jul 2015
2014Final Dividend403 Jul 2014
2014Interim Dividend423 Jan 2014
2013Final Dividend4.511 Jul 2013
2012Final Dividend313 Sep 2012
2011Final Dividend2.814 Jul 2011
2011Interim Dividend321 Oct 2010
2011Interim Dividend714 May 2010
2010Interim Dividend327 Oct 2009
2009Final Dividend509 Jul 2009
2009Interim Dividend329 Oct 2008
2008Final Dividend510 Jul 2008

Bonus

0

No bonus history.

Split

1
YearRatioEx-Date
2010Rs.5/- to Rs.2/-21 Oct 2010
Loading company dashboard...
Fetching ratios, charts, and peers